Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_assertion type Assertion NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_head.
- NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_assertion wasGeneratedBy ECO_0000203 NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_provenance.
- NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_assertion wasDerivedFrom befree-2016 NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_provenance.
- NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_assertion SIO_000772 16585193 NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_provenance.
- NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_assertion evidence source_evidence_literature NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_provenance.
- NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_assertion description "[This set of tumors was selected for having either 11q loss or MYCN amplification, abnormalities that define the two most common genetic subtypes of metastatic neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP543320.RAGpHDSBJ2OTjo9OFEAbA2Kjw9bmn1xWtZ1YmCiuhvh3o130_provenance.